Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
The nosocomial pathogen Clostridioides difficile is a burden to the healthcare system. Gut microbiome disruption, most commonly by broad-spectrum antibiotic treatment, is well established to generate a state that is susceptible to CDI. A variety of metabolites produced by the host and/or gut microbi...
Main Authors: | Andrea Martinez Aguirre, Joseph A. Sorg |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2022.2094672 |
Similar Items
-
The Immune Protein Calprotectin Impacts <named-content content-type="genus-species">Clostridioides difficile</named-content> Metabolism through Zinc Limitation
by: Christopher A. Lopez, et al.
Published: (2019-12-01) -
Metabolic Reprogramming of Clostridioides difficile During the Stationary Phase With the Induction of Toxin Production
by: Julia D. Hofmann, et al.
Published: (2018-08-01) -
Gut Microbiota–Gut Metabolites and <i>Clostridioides difficile</i> Infection: Approaching Sustainable Solutions for Therapy
by: Bijay Gurung, et al.
Published: (2024-01-01) -
Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
by: Meina Neumann-Schaal, et al.
Published: (2019-02-01) -
Characterizing metabolic drivers of Clostridioides difficile infection with activity-based hydrazine probes
by: Katelyn A. Bustin, et al.
Published: (2023-01-01)